Skip to content

Use of Low Cost Prostheses to Improve Upper Extremity Function in Children With Cerebral Palsy

Use of Low Cost Prostheses to Improve Upper Extremity Function in Children With Cerebral Palsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03122171
Enrollment
6
Registered
2017-04-20
Start date
2017-04-01
Completion date
2020-01-13
Last updated
2020-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Prosthesis User

Brief summary

The purpose of the study is to assess the effectiveness of an upper extremity prosthesis in improving the upper extremity function of children with cerebral palsy who have limited use of their hands. Twelve children, aged 4-17 years, who have cerebral palsy and limitations in their ability to use their hands, will be enrolled. All participants will be fitted with a 3D printed arm/hand prosthesis and receive 8 occupational therapy sessions. Each subject will be evaluated pre-treatment, post-occupational therapy sessions and at 6 months follow-up. The evaluation will include assessment of (1)passive and active arm/hand movement and (2)functional hand skills using several standardized tests. The results from the pre-treatment and the two post-treatment evaluations will be compared.

Interventions

Each occupational therapy treatment will be a one-hour standardized session that will include the following: stretching/strengthening (approximately 20 minutes), bi-manual training (approximately 20 minutes), and activities of daily living (approximately 20 minutes).

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis: cerebral palsy * 4-17 years old * MACS levels III - V * Active movement of wrist or elbow

Exclusion criteria

* MACS levels I, II * Botox or orthopedic surgery in past 6 months * Severe contractures * Lack of voluntary arm motion

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Clinically Significant Increase in Assisting Hand Assessment (AHA) ScoreWeek 8The Assisting Hand Assessment (AHA) is a test of hand function in children with difficulties using one of their hands. The AHA measures how effectively the affected hand and arm is used in bimanual performance. An assessment is performed by observing the child's spontaneous handling of toys in a relaxed and playful session. Scores based on 22-items on a 4-point rating scale evaluating quality of the performance (1=does not do, 4=effective). The range of sum scores is 22-88 points. A clinical significant increase in score indicates an increase in quality of performance.
Number of Participants With Increase in Pediatric Motor Ability Log (PMAL) Scores Post-Treatment8 weeksThe PMAL is a structured interview in which the caregiver reports How Often (amount) and How Well (quality of movement) the child uses their involved upper limb when completing 22 activities of daily living. Scores range from 0-10; the higher the score, the better the quality of movement. An increase in PMAL score indicates a higher amount of upper extremity use and better quality of movement.
Number of Participants With Increase in Melbourne Assessment 2 (MA2) ScoresWeek 8The Melbourne Assessment 2 (MA2) is a valid and reliable criterion-referenced test for evaluating four elements of upper limb movement quality in children with a neurological impairment aged 2.5 to 15 years: (i) Range of motion, (ii) Accuracy of reach and placement, (iii) Dexterity of grasp, release and manipulation and (iv) Fluency of movement. An increase in score indicates an increase in upper limb movement quality.

Secondary

MeasureTime frameDescription
Number of Participants With Increase in Pediatric Quality of Life Inventory Subtest Scores Post-Treatment8 weeksThe PedsQL is a brief, standardized, generic assessment instrument that systematically assesses patients' and parents' perceptions of HRQOL in pediatric patients with chronic health conditions using pediatric cancer as an exemplary model. 7 sub-tests will be reported on. Higher scores indicate better HRQOL (Health-Related Quality of Life), an increase in score indicates an increase in HRQOL.

Countries

United States

Participant flow

Participants by arm

ArmCount
Prosthesis
Occupational Therapy Treatment: Each occupational therapy treatment will be a one-hour standardized session that will include the following: stretching/strengthening (approximately 20 minutes), bi-manual training (approximately 20 minutes), and activities of daily living (approximately 20 minutes).
6
Total6

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicProsthesis
Age, Continuous15.8 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants
Race (NIH/OMB)
White
0 Participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 6
other
Total, other adverse events
0 / 6
serious
Total, serious adverse events
0 / 6

Outcome results

Primary

Number of Participants With Clinically Significant Increase in Assisting Hand Assessment (AHA) Score

The Assisting Hand Assessment (AHA) is a test of hand function in children with difficulties using one of their hands. The AHA measures how effectively the affected hand and arm is used in bimanual performance. An assessment is performed by observing the child's spontaneous handling of toys in a relaxed and playful session. Scores based on 22-items on a 4-point rating scale evaluating quality of the performance (1=does not do, 4=effective). The range of sum scores is 22-88 points. A clinical significant increase in score indicates an increase in quality of performance.

Time frame: Week 8

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ProsthesisNumber of Participants With Clinically Significant Increase in Assisting Hand Assessment (AHA) Score4 Participants
Primary

Number of Participants With Increase in Melbourne Assessment 2 (MA2) Scores

The Melbourne Assessment 2 (MA2) is a valid and reliable criterion-referenced test for evaluating four elements of upper limb movement quality in children with a neurological impairment aged 2.5 to 15 years: (i) Range of motion, (ii) Accuracy of reach and placement, (iii) Dexterity of grasp, release and manipulation and (iv) Fluency of movement. An increase in score indicates an increase in upper limb movement quality.

Time frame: Week 8

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ProsthesisNumber of Participants With Increase in Melbourne Assessment 2 (MA2) ScoresRange of Motion4 Participants
ProsthesisNumber of Participants With Increase in Melbourne Assessment 2 (MA2) ScoresAccuracy of Reach and Placement3 Participants
ProsthesisNumber of Participants With Increase in Melbourne Assessment 2 (MA2) ScoresDexterity of Grasp3 Participants
ProsthesisNumber of Participants With Increase in Melbourne Assessment 2 (MA2) ScoresFluency of Movement2 Participants
Primary

Number of Participants With Increase in Pediatric Motor Ability Log (PMAL) Scores Post-Treatment

The PMAL is a structured interview in which the caregiver reports How Often (amount) and How Well (quality of movement) the child uses their involved upper limb when completing 22 activities of daily living. Scores range from 0-10; the higher the score, the better the quality of movement. An increase in PMAL score indicates a higher amount of upper extremity use and better quality of movement.

Time frame: 8 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ProsthesisNumber of Participants With Increase in Pediatric Motor Ability Log (PMAL) Scores Post-Treatment4 Participants
Secondary

Number of Participants With Increase in Pediatric Quality of Life Inventory Subtest Scores Post-Treatment

The PedsQL is a brief, standardized, generic assessment instrument that systematically assesses patients' and parents' perceptions of HRQOL in pediatric patients with chronic health conditions using pediatric cancer as an exemplary model. 7 sub-tests will be reported on. Higher scores indicate better HRQOL (Health-Related Quality of Life), an increase in score indicates an increase in HRQOL.

Time frame: 8 weeks

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ProsthesisNumber of Participants With Increase in Pediatric Quality of Life Inventory Subtest Scores Post-TreatmentDaily Activities3 Participants
ProsthesisNumber of Participants With Increase in Pediatric Quality of Life Inventory Subtest Scores Post-TreatmentSchool Activities3 Participants
ProsthesisNumber of Participants With Increase in Pediatric Quality of Life Inventory Subtest Scores Post-TreatmentMovement and Balance3 Participants
ProsthesisNumber of Participants With Increase in Pediatric Quality of Life Inventory Subtest Scores Post-TreatmentPain and Hurt2 Participants
ProsthesisNumber of Participants With Increase in Pediatric Quality of Life Inventory Subtest Scores Post-TreatmentFatigue1 Participants
ProsthesisNumber of Participants With Increase in Pediatric Quality of Life Inventory Subtest Scores Post-TreatmentEating Activities1 Participants
ProsthesisNumber of Participants With Increase in Pediatric Quality of Life Inventory Subtest Scores Post-TreatmentSpeech and Communication1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026